SmartECG goals and stakeholders

Patients: faster diagnosis, better treatment and potentially millions of saved lives

For patients SmartECG means faster diagnosis and better treatment of cardiovascular diseases. Today, it is common that GP’s will limit the number of patients they refer to the tests since they know that the waiting lists are too long already (suppressed demand).

SmartECG and primary care level analysis also reduce patients´ costs and inconveniences related to specialist physicians’ visits and additional analysis. Only most acute CVD patients need to be transferred to secondary care level for more detailed analysis. The initial CVD diagnosing time should thus reduce from current 1-3 months to just few days. Faster diagnosis leads to faster treatment and will result in potentially millions of saved lives.

Better decision-making tools for the primary care physicians

The SmartECG is expected to increase primary care level specialists’ competencies in early ECG diagnosing and for requesting more specific consultations from specialist physicians. Primary care physicians can make cardiac decisions either based on SmartECG findings or order an additional specialist consultation via the integrated platform. The GPs are provided with effective diagnostic tools and simple specialist consultation platforms to increase their competencies and options in CVD diagnosing and treatment decision making.

Specialist physicians able to concentrate in patients in need of treatment

SmartECG automatic data analysis and pre-selection can reduce the total data amount by 99% and present physicians only the most relevant bits of analysis data. This enables to perform 2-3 times longer and more detailed ECG analysis

Reduced waiting lists and better use of resources for healthcare organisations

Based on our private studies using data from Finland (2013), about 70% of long-term ECG consultation reports do not recommend secondary care studies and they can be avoided by more competent primary care analysis. This will reduce healthcare waiting lists, avoid duplicating analysis and lower the treatment cost per patient. It is expected that by 2020, around 46% of long ECG analysis are done at primary care level.

Our goal is to create automatic plug-and-play compatibility for 80% of ECG analysis equipment in primary care level and achieve full compatibility with most eHealth systems in targeted countries by 2020.

Healthcare organisations have total control on their cost through the co-operation models of pay-per-use and fixed annual subscriptions payments.

The SmartECG platform will be easy to use, and any end-user can be trained within 15 minutes.

The browser-based interface also ensures fastest updates, universal customer support and best scale-up.

The consulting specialists

The consulting specialists that provide primary care physicians the cardiac consultations needed, will be paid for per each remote consultation, depending on their set cost and rewarded either monthly or quarterly, depending on the number of their completed consultations.

Healthcare system in general

The SmartECG service will be covered by healthcare reimbursement schemes in EU and in most other regions, depending on national regulations.

Device manufacturers

Our goal is to create automatic plug-and-play compatibility for 80% of ECG analysis equipment in primary care level and achieve full compatibility with most eHealth systems in targeted countries by 2020.

Device manufacturers will benefit from SmartECG by being able to support the healthcare organisations in the secondary care to treat the cardiac patients at the right time with the high-quality monitoring devices.

Top